Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Akebia Ther

AKBA

Akebia Ther

Akebia Ther historical holders

total: 2

Abrams Capital Management Akebia Ther transactions over time

Total transactions:
3
New positions:
1
Sold out:
1
Added:
1
Held since:
2018 Q3
Held for:
9 quarters
Latest activity:
2020 Q4
David Abrams has been an institutional investor in Akebia Ther (AKBA) since 2018 Q3. According to 2026 Q1 report, David Abrams doesn't hold any shares. The fund/company first acquired AKBA in 2018 Q3, initially purchasing about 1.12M shares. Since the initial investment, Abrams Capital Management has made 2 more transactions in this position.

When did David Abrams exit their AKBA position?

David Abrams no longer holds Akebia Ther (AKBA). They sold off their entire position in 2020 Q4, closing out an investment that began in 2018 Q3.

When did David Abrams first invest in AKBA?

David Abrams first invested in Akebia Ther (AKBA) in 2018 Q3 at the reported quarter-end price of $8.83 per share, acquiring 1,119,286 shares in their initial purchase.

What is David Abrams's average cost basis for AKBA?

Based on historical transaction data, David Abrams's estimated cost basis for Akebia Ther (AKBA) is approximately $6.18 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$6.18
Weighted AVG sell price:
$2.51

AKBA transactions history by Abrams Capital Management

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2020 Q4
0.00%
$2.51
-100% (-5,656,462)
2018 Q4
1.29%
$5.53
+405.36% (+4,537,176)
2018 Q3
0.26%
$8.83
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.